Amid efforts to streamline and commercialize R&D portfolios and deploy broader corporate resources most efficiently, employees both at home and abroad at several Japanese pharmaceutical companies are facing layoffs in the latter half in 2024.
Japan Pharma Layoffs: Takeda And Others Implementing Broad Cuts
Several major Japanese firms, including Takeda, are planning layoffs at home and elsewhere as they make efforts to streamline their business and costs and cope with R&D and commercial challenges.
